Basic Information
| LncRNA/CircRNA Name | RP11-466I1.1 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR etc. |
| Sample | hepatocellular carcinoma tissues |
| Expression Pattern | up-regulated |
| Function Description | Results showed that RP11-466I1.1 was upregulated in HCC tissues (P < .01) and serum (P < .05). This study suggested that RP11-466I1.1 is distinctively expressed in HCC and may serve as a promising novel prognostic biomarker. |
| Pubmed ID | 29790663 |
| Year | 2018 |
| Title | A distinctively expressed long noncoding RNA, RP11??66I1.1, may serve as a prognostic biomarker in hepatocellular carcinoma |
External Links
| Links for RP11-466I1.1 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |